Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ki E Park

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Current Pharmaceutical Design|May 7, 2016
Prognostic Significance of Asymptomatic Myocardial Ischemia in Women vs. MenKi E Park, C Richard Conti
Expert Review of Cardiovascular Therapy|November 23, 2011
Microvascular dysfunction: What have we learned from WISE?Ki E Park, Carl J Pepine
Expert Review of Cardiovascular Therapy|July 31, 2010
Bone marrow-derived cells and hypertensionKi E Park, Carl J Pepine
Trends in Cardiovascular Medicine|November 22, 2017
Non-PCI/CABG therapies for refractory anginaKi E Park, C Richard Conti
Cleveland Clinic Journal of Medicine|July 13, 2010
Pathophysiologic mechanisms linking impaired cardiovascular health and neurologic dysfunction: the year in reviewKi E Park, Carl J Pepine
Trends in Cardiovascular Medicine|December 4, 2014
Assessing cardiovascular risk in women: looking beyond traditional risk factorsKi E Park, Carl J Pepine
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|July 7, 2020
Diabetes and cardiovascular disease, are women protected or at higher risk?Nathan Gargus, Ki E Park, David E Winchester
Cardiology and Therapy|June 15, 2020
Home-Based Cardiac Rehabilitation (HBCR) In Post-TAVR Patients: A Prospective, Single-Center, Cohort, Pilot StudyGurjaspreet K Bhattal, Ki E Park, David E Winchester
Interventional Cardiology Clinics|November 13, 2024
Optimal Approaches for Pregnant Patients Undergoing Percutaneous Coronary InterventionSarah A Goldstein, Ki E Park, Kathryn J Lindley
Clinical Cardiology|October 27, 2011
Efficacy and safety of unfractionated heparin plus glycoprotein IIb/IIIa inhibitors during revascularization for an acute coronary syndrome: a meta-analysis of randomized trials performed with stents and thienopyridinesDavid E Winchester, William D Brearley, Xuerong Wen, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Current Pharmaceutical Design|May 7, 2016
Prognostic Significance of Asymptomatic Myocardial Ischemia in Women vs. MenKi E Park, C Richard Conti
Expert Review of Cardiovascular Therapy|November 23, 2011
Microvascular dysfunction: What have we learned from WISE?Ki E Park, Carl J Pepine
Expert Review of Cardiovascular Therapy|July 31, 2010
Bone marrow-derived cells and hypertensionKi E Park, Carl J Pepine
Trends in Cardiovascular Medicine|November 22, 2017
Non-PCI/CABG therapies for refractory anginaKi E Park, C Richard Conti
Cleveland Clinic Journal of Medicine|July 13, 2010
Pathophysiologic mechanisms linking impaired cardiovascular health and neurologic dysfunction: the year in reviewKi E Park, Carl J Pepine
Trends in Cardiovascular Medicine|December 4, 2014
Assessing cardiovascular risk in women: looking beyond traditional risk factorsKi E Park, Carl J Pepine
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|July 7, 2020
Diabetes and cardiovascular disease, are women protected or at higher risk?Nathan Gargus, Ki E Park, David E Winchester
Cardiology and Therapy|June 15, 2020
Home-Based Cardiac Rehabilitation (HBCR) In Post-TAVR Patients: A Prospective, Single-Center, Cohort, Pilot StudyGurjaspreet K Bhattal, Ki E Park, David E Winchester
Interventional Cardiology Clinics|November 13, 2024
Optimal Approaches for Pregnant Patients Undergoing Percutaneous Coronary InterventionSarah A Goldstein, Ki E Park, Kathryn J Lindley
Clinical Cardiology|October 27, 2011
Efficacy and safety of unfractionated heparin plus glycoprotein IIb/IIIa inhibitors during revascularization for an acute coronary syndrome: a meta-analysis of randomized trials performed with stents and thienopyridinesDavid E Winchester, William D Brearley, Xuerong Wen, et al.
Pageof 3